[Form 4] UNITEDHEALTH GROUP INC Insider Trading Activity
Timothy P. Flynn, a director of UnitedHealth Group Inc. (UNH), received 272 deferred stock units on 10/01/2025 as regular quarterly director compensation at a reported price of $0. The filing shows 9,810 shares beneficially owned following the transaction and an additional 6,033 shares held indirectly by trust. The form explains these deferred stock units are immediately vested but must be retained until the director leaves the board. The Form 4 was signed by an attorney-in-fact and dated 10/03/2025.
- 272 deferred stock units granted as regular director compensation, reflecting continued alignment with shareholder interests
- Deferred stock units are immediately vested, giving the director ownership rights upon grant
- Retention requirement until board service completion promotes long-term alignment
- Form 4 discloses both direct (9,810) and indirect (6,033) holdings, providing transparency
- None.
Insights
Director received routine deferred stock units; retention until service end aligns with long-term alignment.
The filing documents a standard compensation practice: 272 deferred stock units granted as quarterly director pay and immediately vested but subject to mandatory retention until board service ends. This structure encourages retention of equity-based compensation without immediate sale.
The report lists 9,810 shares beneficially owned and 6,033 shares held indirectly by trust, clarifying the director's current equity stake as disclosed.
Grant is routine, non-cash director compensation; no purchase price and immediate vesting noted.
The transaction code and the $0 price indicate the units were awarded, not purchased. Immediate vesting means Flynn has ownership rights, while the retention requirement restricts disposition until departure from the board.
This is a regular quarterly award, so the transaction appears procedural rather than a material change in ownership percentage.